Somatostatin for Uveitic Cystoid Macular Edema (CME).
作者信息
Papadaki Thekla, Zacharopoulos Ioannis, Iaccheri Barbara, Fiore Tito, Foster C Stephen
机构信息
Ocular Immunology and Uveitis Service, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, MA, USA.
出版信息
Ocul Immunol Inflamm. 2005 Dec;13(6):469-70. doi: 10.1080/09273940691001964.
PURPOSE
To report the favorable response of bilateral recalcitrant uveitic cystoid macular edema (CME) to treatment with a somatostatin analog.
METHODS
Medical ophthalmic history and the results of ophthalmic examinations were recorded. Fluorescein angiography (FA) studies were reviewed.
RESULTS
A 52-year-old white female with intermediate uveitis developed bilateral recalcitrant CME. Treatment with subcutaneous injections of the somatostatin analog octreotide resulted in partial resolution of the CME and improvement of visual acuity.
CONCLUSIONS
Somatostatin may play a role in the treatment of CME secondary to uveitis.
Zotero 插件